-
Signature
-
/s/ Julia Wright, as attorney-in-fact
-
Stock symbol
-
CHX
-
Transactions as of
-
Nov 1, 2022
-
Transactions value $
-
-$1,285,810
-
Form type
-
4
-
Date filed
-
11/3/2022, 04:45 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CHX |
Common Stock |
Options Exercise |
$165K |
+48.4K |
+9.06% |
$3.41* |
582K |
Nov 1, 2022 |
Direct |
|
transaction |
CHX |
Common Stock |
Sale |
-$1.45M |
-48.4K |
-8.31% |
$30.00 |
533K |
Nov 1, 2022 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CHX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-48.4K |
-100% |
$0.00* |
0 |
Nov 1, 2022 |
Common Stock |
48.4K |
$3.41 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Operating Officer and President, Chemical Technologies